Position in PCVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$623,965
+$127,068 QoQ
Shares Held
10,734
+25.5% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#184
of 329 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ROYAL BANK OF CANADA holds $2,116,200,518 across 427 Biotechnology names. PCVX ranks #69 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
6,182,479 | $490,208,754 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
980,259 | $486,924,048 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
875,859 | $263,659,830 | |
| 4 | INCY |
Incyte Corp
|
1,132,050 | $128,329,182 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
174,515 | $108,817,078 | |
| 6 | MRNA |
Moderna, Inc.
|
944,457 | $66,140,319 | |
| 7 | INSM |
INSMED Inc
|
416,487 | $44,405,840 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
545,761 | $42,716,712 |
All Filings in PCVX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $623,965 | 10,734 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $496,897 | 8,551 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $425,593 | 9,224 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $34,184,742 | 949,049 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $24,362,731 | 749,392 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $1,112,822 | 29,471 | Shares | Defined | 2025-11-21 | |
| 2024-12-31 | $1,121,234 | 13,697 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $970,151 | 8,490 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $832,948 | 11,031 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $224,668 | 3,289 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $1,805,499 | 28,750 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $609,007 | 11,946 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $300,638 | 6,020 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $158,951 | 4,241 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $493,690 | 10,296 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $20,568 | 857 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $10,836 | 498 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $68,078 | 2,819 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $206,425 | 8,677 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $123,982 | 4,887 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $65,774 | 2,922 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $49,454 | 2,504 | Shares | Defined | 2021-07-20 | |
| 2020-12-31 | $13,949 | 525 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $10,863 | 220 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $6,322 | 200 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||